Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1997 Jan;166(1):45–55.

Lung transplantation. Part II. Postoperative management and results.

D E Wood 1, G Raghu 1
PMCID: PMC1303955  PMID: 9074338

Abstract

In part I of this 2-part article on lung transplantation (Western Journal of Medicine 1996; 165:355-363), we reviewed the current indications and operative techniques of the procedure. In part II, we describe the postoperative management and results of lung transplantation. We also discuss current controversies, such as the use of marginal donors, living-related transplants, marginal recipients, and single-versus double-lung transplantation for emphysema or pulmonary hypertension.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. M., Kormos R. L., Stuart R. S., Fricker F. J., Griffith B. P., Nalesnik M., Hardesty R. L., Dummer J. S. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991 Nov-Dec;10(6):877–887. [PubMed] [Google Scholar]
  2. Bando K., Paradis I. L., Keenan R. J., Yousem S. A., Komatsu K., Konishi H., Guilinger R. A., Masciangelo T. N., Pham S. M., Armitage J. M. Comparison of outcomes after single and bilateral lung transplantation for obstructive lung disease. J Heart Lung Transplant. 1995 Jul-Aug;14(4):692–698. [PubMed] [Google Scholar]
  3. Bando K., Paradis I. L., Similo S., Konishi H., Komatsu K., Zullo T. G., Yousem S. A., Close J. M., Zeevi A., Duquesnoy R. J. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg. 1995 Jul;110(1):4–14. doi: 10.1016/S0022-5223(05)80003-0. [DOI] [PubMed] [Google Scholar]
  4. Barr M. L., Schenkel F. A., Cohen R. G., Chan K. M., Barbers R. G., Marboe C. C., Starnes V. A. Living-related lobar transplantation: recipient outcome and early rejection patterns. Transplant Proc. 1995 Jun;27(3):1995–1996. [PubMed] [Google Scholar]
  5. Cagle P. T., Buffone G., Holland V. A., Samo T., Demmler G. J., Noon G. P., Lawrence E. C. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest. 1992 Jan;101(1):93–96. doi: 10.1378/chest.101.1.93. [DOI] [PubMed] [Google Scholar]
  6. Calhoon J. H., Grover F. L., Gibbons W. J., Bryan C. L., Levine S. M., Bailey S. R., Nichols L., Lum C., Trinkle J. K. Single lung transplantation. Alternative indications and technique. J Thorac Cardiovasc Surg. 1991 May;101(5):816–825. [PubMed] [Google Scholar]
  7. Cohen R. G., Barr M. L., Schenkel F. A., DeMeester T. R., Wells W. J., Starnes V. A. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg. 1994 Jun;57(6):1423–1428. doi: 10.1016/0003-4975(94)90095-7. [DOI] [PubMed] [Google Scholar]
  8. Cooper J. D., Patterson G. A., Trulock E. P. Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. J Thorac Cardiovasc Surg. 1994 Feb;107(2):460–471. [PubMed] [Google Scholar]
  9. Couetil J. P., Houssin D. P., Soubrane O., Chevalier P. G., Dousset B. E., Loulmet D., Achkar A., Tolan M. J., Amrein C. I., Guinvarch A. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg. 1995 Nov;110(5):1415–1423. doi: 10.1016/s0022-5223(95)70064-1. [DOI] [PubMed] [Google Scholar]
  10. Couraud L., Baudet E., Martigne C., Roques X., Velly J. F., Laborde N., Dubrez J., Clerc F., Dromer C., Vallieres E. Bronchial revascularization in double-lung transplantation: a series of 8 patients. Bordeaux Lung and Heart-Lung Transplant Group. Ann Thorac Surg. 1992 Jan;53(1):88–94. doi: 10.1016/0003-4975(92)90764-u. [DOI] [PubMed] [Google Scholar]
  11. Daly R. C., Tadjkarimi S., Khaghani A., Banner N. R., Yacoub M. H. Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg. 1993 Oct;56(4):885–892. doi: 10.1016/0003-4975(93)90350-q. [DOI] [PubMed] [Google Scholar]
  12. Davis R. D., Jr, Pasque M. K. Pulmonary transplantation. Ann Surg. 1995 Jan;221(1):14–28. doi: 10.1097/00000658-199501000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Duncan A. J., Dummer J. S., Paradis I. L., Dauber J. H., Yousem S. A., Zenati M. A., Kormos R. L., Griffith B. P. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant. 1991 Sep-Oct;10(5 Pt 1):638–646. [PubMed] [Google Scholar]
  14. Duncan S. R., Grgurich W. F., Iacono A. T., Burckart G. J., Yousem S. A., Paradis I. L., Williams P. A., Johnson B. A., Griffith B. P. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med. 1994 Jul;150(1):146–152. doi: 10.1164/ajrccm.150.1.8025741. [DOI] [PubMed] [Google Scholar]
  15. Duncan S. R., Paradis I. L., Dauber J. H., Yousem S. A., Hardesty R. L., Griffith B. P. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1213–1215. doi: 10.1164/ajrccm/146.5_Pt_1.1213. [DOI] [PubMed] [Google Scholar]
  16. Egan J. J., Barber L., Lomax J., Fox A., Yonan N., Rahman A. N., Campbell C. S., Deiraniya A. K., Carroll K. B., Craske J. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax. 1995 Jan;50(1):9–13. doi: 10.1136/thx.50.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ferry J. A., Jacobson J. O., Conti D., Delmonico F., Harris N. L. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol. 1989 Nov;2(6):583–592. [PubMed] [Google Scholar]
  18. Flume P. A., Egan T. M., Paradowski L. J., Detterbeck F. C., Thompson J. T., Yankaskas J. R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. doi: 10.1164/ajrccm.149.6.7516251. [DOI] [PubMed] [Google Scholar]
  19. Griffith B. P., Bando K., Armitage J. M., Hattler B. G., Keenan R. J., Hardesty R. L., Komatsu K., Konishi H., Paradis I. L. Lung transplantation at the University of Pittsburgh. Clin Transpl. 1992:149–159. [PubMed] [Google Scholar]
  20. Gross C. R., Savik K., Bolman R. M., 3rd, Hertz M. I. Long-term health status and quality of life outcomes of lung transplant recipients. Chest. 1995 Dec;108(6):1587–1593. doi: 10.1378/chest.108.6.1587. [DOI] [PubMed] [Google Scholar]
  21. Hennington M. H., D'Armini A. M., Lemasters J. J., Egan T. M. Cadaver lungs for transplantation. Effect of ventilation with alveolar gas. Transplantation. 1996 Apr 15;61(7):1009–1014. doi: 10.1097/00007890-199604150-00004. [DOI] [PubMed] [Google Scholar]
  22. Ho M. Advances in understanding cytomegalovirus infection after transplantation. Transplant Proc. 1994 Oct;26(5 Suppl 1):7–11. [PubMed] [Google Scholar]
  23. Hutter J. A., Scott J., Wreghitt T., Higenbottam T., Wallwork J. The importance of cytomegalovirus in heart-lung transplant recipients. Chest. 1989 Mar;95(3):627–631. doi: 10.1378/chest.95.3.627. [DOI] [PubMed] [Google Scholar]
  24. Kelly J. L., Albert R. K., Wood D. E., Raghu G. Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients. Transplantation. 1995 Apr 27;59(8):1144–1147. [PubMed] [Google Scholar]
  25. Koskinen P. K., Nieminen M. S., Mattila S. P., Häyry P. J., Lautenschlager I. T. The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients. Transplantation. 1993 Mar;55(3):547–551. doi: 10.1097/00007890-199303000-00017. [DOI] [PubMed] [Google Scholar]
  26. Kramer M. R., Sprung C. L. Living related donation in lung transplantation. Ethical considerations. Arch Intern Med. 1995 Sep 11;155(16):1734–1738. [PubMed] [Google Scholar]
  27. Kron I. L., Tribble C. G., Kern J. A., Daniel T. M., Rose C. E., Truwit J. D., Blackbourne L. H., Bergin J. D. Successful transplantation of marginally acceptable thoracic organs. Ann Surg. 1993 May;217(5):518–524. doi: 10.1097/00000658-199305010-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Leblond V., Sutton L., Dorent R., Davi F., Bitker M. O., Gabarre J., Charlotte F., Ghoussoub J. J., Fourcade C., Fischer A. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol. 1995 Apr;13(4):961–968. doi: 10.1200/JCO.1995.13.4.961. [DOI] [PubMed] [Google Scholar]
  29. Levy R. D., Ernst P., Levine S. M., Shennib H., Anzueto A., Bryan C. L., Calhoon J. H., Trinkle J. K., Jenkinson S. G., Gibbons W. J. Exercise performance after lung transplantation. J Heart Lung Transplant. 1993 Jan-Feb;12(1 Pt 1):27–33. [PubMed] [Google Scholar]
  30. Lima O., Goldberg M., Peters W. J., Ayabe H., Townsend E., Cooper J. D. Bronchial omentopexy in canine lung transplantation. J Thorac Cardiovasc Surg. 1982 Mar;83(3):418–421. [PubMed] [Google Scholar]
  31. Miller J. D., DeHoyos A. An evaluation of the role of omentopexy and of early perioperative corticosteroid administration in clinical lung transplantation. The University of Toronto and Washington University Lung Transplant Programs. J Thorac Cardiovasc Surg. 1993 Feb;105(2):247–252. [PubMed] [Google Scholar]
  32. Montoya A., Mawulawde K., Houck J., Sullivan H., Lonchyna V., Blakeman B., Hinkamp T., Garrity E., Pifarre R. Survival and functional outcome after single and bilateral lung transplantation. Loyola Lung Transplant Team. Surgery. 1994 Oct;116(4):712–718. [PubMed] [Google Scholar]
  33. Nalesnik M. A., Jaffe R., Starzl T. E., Demetris A. J., Porter K., Burnham J. A., Makowka L., Ho M., Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988 Oct;133(1):173–192. [PMC free article] [PubMed] [Google Scholar]
  34. Oh C. S., Stratta R. J., Fox B. C., Sollinger H. W., Belzer F. O., Maki D. G. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation. 1988 Jan;45(1):68–73. doi: 10.1097/00007890-198801000-00016. [DOI] [PubMed] [Google Scholar]
  35. Paradis I., Yousem S., Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med. 1993 Dec;14(4):751–763. [PubMed] [Google Scholar]
  36. Patel R., Snydman D. R., Rubin R. H., Ho M., Pescovitz M., Martin M., Paya C. V. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation. 1996 May 15;61(9):1279–1289. doi: 10.1097/00007890-199605150-00001. [DOI] [PubMed] [Google Scholar]
  37. Ramsey S. D., Patrick D. L., Albert R. K., Larson E. B., Wood D. E., Raghu G. The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest. 1995 Dec;108(6):1594–1601. doi: 10.1378/chest.108.6.1594. [DOI] [PubMed] [Google Scholar]
  38. Randhawa P. S., Yousem S. A., Paradis I. L., Dauber J. A., Griffith B. P., Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989 Aug;92(2):177–185. doi: 10.1093/ajcp/92.2.177. [DOI] [PubMed] [Google Scholar]
  39. Schäfers H. J., Haverich A., Wagner T. O., Wahlers T., Alken A., Borst H. G. Decreased incidence of bronchial complications following lung transplantation. Eur J Cardiothorac Surg. 1992;6(4):174–179. doi: 10.1016/1010-7940(92)90213-h. [DOI] [PubMed] [Google Scholar]
  40. Shennib H., Massard G. Airway complications in lung transplantation. Ann Thorac Surg. 1994 Feb;57(2):506–511. doi: 10.1016/0003-4975(94)91038-3. [DOI] [PubMed] [Google Scholar]
  41. Snell G. I., de Hoyos A., Krajden M., Winton T., Maurer J. R. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993 Feb;103(2):466–471. doi: 10.1378/chest.103.2.466. [DOI] [PubMed] [Google Scholar]
  42. Starnes V. A., Barr M. L., Cohen R. G. Lobar transplantation. Indications, technique, and outcome. J Thorac Cardiovasc Surg. 1994 Sep;108(3):403–411. [PubMed] [Google Scholar]
  43. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E. P., Cooper J. D., Patterson G. A. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995 Jun;109(6):1075–1080. doi: 10.1016/S0022-5223(95)70190-7. [DOI] [PubMed] [Google Scholar]
  44. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E. P., Cooper J. D., Patterson G. A. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995 Jun;109(6):1075–1080. doi: 10.1016/S0022-5223(95)70190-7. [DOI] [PubMed] [Google Scholar]
  45. Sundaresan S., Trulock E. P., Mohanakumar T., Cooper J. D., Patterson G. A. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg. 1995 Nov;60(5):1341–1347. doi: 10.1016/0003-4975(95)00751-6. [DOI] [PubMed] [Google Scholar]
  46. Swinnen L. J., Mullen G. M., Carr T. J., Costanzo M. R., Fisher R. I. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood. 1995 Nov 1;86(9):3333–3340. [PubMed] [Google Scholar]
  47. Trulock E. P. Management of lung transplant rejection. Chest. 1993 May;103(5):1566–1576. doi: 10.1378/chest.103.5.1566. [DOI] [PubMed] [Google Scholar]
  48. Wreghitt T. G., Hakim M., Gray J. J., Kucia S., Wallwork J., English T. A. Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol. 1988 Jun;41(6):660–667. doi: 10.1136/jcp.41.6.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. de Hoyos A. L., Patterson G. A., Maurer J. R., Ramirez J. C., Miller J. D., Winton T. L. Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992 Feb;103(2):295–306. [PubMed] [Google Scholar]
  50. van den Berg A. P., Klompmaker I. J., Haagsma E. B., Scholten-Sampson A., Bijleveld C. M., Schirm J., van der Giessen M., Slooff M. J., The T. H. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis. 1991 Aug;164(2):265–270. doi: 10.1093/infdis/164.2.265. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES